Partial pol Sequences from Drug Naive HIV-2 Infected Individuals from Maharashtra,India

Abstract

HIV-2 is important due to its unique challenges in diagnosis, treatment, and drug resistance. The data on Indian HIV-2 pol gene as well as resistance to antiretroviral drugs are limited. Here we report sequence data of protease (PR) and reverse transcriptase (RT) genes from HIV-2 infected treatment naive individuals (N = 32) from Maharashtra, India. These sequences were found to be closely related to HIV-2 subtype A sequences from Guinea Bissau. We observed two unique residues at positions 14 and 70 in the PR region specific to Indian HIV-2. Mutations associated with resistance to RT and protease inhibitors were observed in 3 of 32 (9.37%) samples. To our knowledge, this is the first study from India to report drug resistance among treatment naive HIV-2 infected individuals. The results emphasize need for larger nationwide surveillance for HIV-2 drug resistance to better understand the primary drug resistance among HIV-2 infected individuals.

Get full access to this article

View all access options for this article.

References

Agrawal

, Sawant

, Shastri

: Prevalence of HIV-2 infection in Mumbai. Indian J Dermatol Venereol Leprol, 2010; 76:709–710.

Murugan

, Anburajan

: Prevalence of HIV-2 infection in south Tamil Nadu. Indian J Sex Transm Dis, 2007; 28:113.

Solomon

, Kumarasamy

, Ganesh

, et al.: Prevalence and risk factors of HIV-1 and HIV-2 infection in urban and rural areas in Tamil Nadu, India. Int J STD AIDS, 1998; 9:98–103.

National AIDS Control Organization (NACO): Annual Report 2016–17, 2016.

Ren

, Bird

, Chamberlain

, et al.: Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc Natl Acad Sci U S A, 2002; 99:14410–14415.

Brandin

, Lindborg

, Gyllensten

, et al.: pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy. AIDS Res Hum Retroviruses, 2003; 19:543–550.

Gurjar

, Ravi

, Desai

: Molecular epidemiology of HIV type 2 infections in South India. AIDS Res Hum Retroviruses, 2009; 25:363–372.

Jadhav

, Tripathy

, Kulkarni

, et al.: Molecular phylogenetics of nearly full-length HIV type 2 envelope gene sequences from West India. AIDS Res Hum Retroviruses, 2009; 25:115–121.

Kannangai

, Shaji

, Ramalingam

, et al.: HIV-2 subtype circulating in India (south). J Acquir Immune Defic Syndr, 2003; 33:219–222.

10.

Kulkarni

, Tripathy

, Agnihotri

, et al.: Indian primary HIV-2 isolates and relationship between V3 genotype, biological phenotype and coreceptor usage. Virology, 2005; 337:68–75.

11.

Korber

, Myers

: Signature pattern analysis: A method for assessing viral sequence relatedness. AIDS Res Hum Retroviruses, 1992; 8:1549–1560.

12.

Charpentier

, Camacho

, Ruelle

, et al.: HIV-2EU-supporting standardized hiv-2 drug-resistance interpretation in Europe: An update. Clin Infect Dis, 2015; 61:1346–1347.

13.

Witvrouw

, Pannecouque

, Switzer

, et al.: Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: Implications for treatment and postexposure prophylaxis. Antivir Ther, 2004; 9:57–65.

14.

Smith

, Anderson

, Pyrak

, et al.: Antiretroviral drug resistance in HIV-2: Three amino acid changes are sufficient for classwide nucleoside analogue resistance. J Infect Dis, 2009; 199:1323–1326.

15.

Deuzing

, Charpentier

, Wright

, et al.: Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses. J Virol, 2015; 89:833–843.

16.

World Health Organization (WHO): Surveillance of HIV Drug Resistance in Adults Initiating Antiretroviral Therapy (Pre-treatment HIV Drug Resistance), 2014.